Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:1011-1021, 2006
DOI: 10.2337/diabetes.55.04.06.db05-1048
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, D.
Right arrow Articles by Bromberg, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, D.
Right arrow Articles by Bromberg, J. S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

CD4+CD25+ Regulatory T-Cells Inhibit the Islet Innate Immune Response and Promote Islet Engraftment

Dongmei Chen1, Nan Zhang1, Shuang Fu2, Bernd Schröppel3, Qiongfen Guo4, Alexandre Garin5, Sergio A. Lira5, and Jonathan S. Bromberg1,5

1 Department of Gene and Cell Medicine, and Recanati/Miller Transplantation Institute, Mount Sinai School of Medicine, New York, New York
2 Institute for Cancer Genetics, Columbia University, New York, New York
3 Division of Nephrology, Mount Sinai School of Medicine, New York, New York
4 Department of Surgery, Columbia University, New York, New York
5 Center for Immunobiology, Mount Sinai School of Medicine, New York, New York

Address correspondence and reprint requests to Dr. Jonathan S. Bromberg, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1104, New York, NY 10029-6574. E-mail: jon.bromberg{at}mountsinai.org

Abbreviations: IFN, interferon; IL, interleukin; mAb, monoclonal antibody; PE, phycoethrin; TGF, transforming growth factor; TNF-{alpha}, tumor necrosis factor-{alpha}

Early islet cell loss is a significant problem in clinical islet cell transplantation. Diverse stress stimuli induce innate immune responses in islets that contribute to ß-cell dysfunction, inflammation, and loss. Here, we show that cytokine-stimulated murine islets express multiple inflammatory chemokines that recruit T-cells and thereby impair islet function in vitro and in vivo. Both nonislet ductal and exocrine elements and the individual islet cellular components contribute to this innate immune response. CD4+CD25+ regulatory T-cells inhibit islet chemokine expression through a cell contact–dependent, soluble factor–independent mechanism and inhibit effector T-cell migration to the islet. Regulatory T-cells can also migrate to stimulated islets. Cotransfer of regulatory T-cells with islets in a transplantation model prevents islet innate immune responses and inflammation and preserves normal architecture and engraftment. Regulatory T-cell inhibition of multiple components of innate immune responses may be a fundamental aspect of their function that influences ischemia-reperfusion injury and adaptive immunity.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.